POVAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Povan, and what generic alternatives are available?
Povan is a drug marketed by Parke Davis and is included in two NDAs.
The generic ingredient in POVAN is pyrvinium pamoate. Additional details are available on the pyrvinium pamoate profile page.
Summary for POVAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | POVAN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for POVAN
US Patents and Regulatory Information for POVAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parke Davis | POVAN | pyrvinium pamoate | SUSPENSION;ORAL | 011964-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Parke Davis | POVAN | pyrvinium pamoate | TABLET;ORAL | 012485-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |